title: Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group.
abstract: A retrospective survey on home parenteral nutrition (HPN) in Europe was performed from January to December 1997. Data were compared to a similar study performed in 1993. A questionnaire of HPN practice was designed by the members of the ESPEN-HAN group. This involved adult patients (older than 16 years) newly registered in an HPN program between 1 January and 31 December 1997 and included: number of patients, underlying diseases and a 6-12 month outcome. Incidence and prevalence (at 1.1.1998) of adult HPN were calculated according to the estimated total population in 1997 for the countries in which more than 80% of HPN patients were reported.A total of 494 patients were registered in 73 centres from nine countries (Belgium (B), Denmark (D), France (F), Poland (P), Spain (S), Sweden (Sw), United Kingdom (UK), The Netherlands (N) and Germany (G). The underlying diseases for HPN in 494 patients were cancer (39%), Crohn's (19%), vascular diseases (15%), radiation enteritis (7%), AIDS (2%), other diseases with intestinal failure (18%). Incidence (patients/million inhabitants/year) were in N (3), F. (2.9), D. (2.8), B. (2.6), UK (1. 2), S (0.7) and P (0.36), respectively. Prevalence were in D. (12.7). U.K. (3.7), N. (3.7), F (3.6), B (3.0), P (1.1), S (0.65). After this 6-12 months follow-up (n=284), the mortality was respectively 4% in Crohn's disease, 13% in vascular diseases, 16% in others, 21% in radiaton enteritis, 34% in AIDS, 74% in cancer. Incidences and prevalences modestly increased in these seven European countries in 1997 in comparison to 1993. The percentages of underlying diseases in these countries remained similar except for AIDS that significantly decreased (from 7% to 2%). Outcomes did not significantly differ in the 4-year period except for AIDS (34% instead of 88% mortality) and could have been related to newer, more efficacious therapy.
authors.affiliation: Department of Gastroenterology, Hôpital Erasme, B1070 Bruxelles, Belgium.
authors.forename: H
authors.initials: H
authors.lastname: Bakker
authors.forename: F
authors.initials: F
authors.lastname: Bozzetti
authors.forename: M
authors.initials: M
authors.lastname: Staun
authors.forename: M
authors.initials: M
authors.lastname: Leon-Sanz
authors.forename: X
authors.initials: X
authors.lastname: Hebuterne
authors.forename: M
authors.initials: M
authors.lastname: Pertkiewicz
authors.forename: J
authors.initials: J
authors.lastname: Shaffer
authors.forename: P
authors.initials: P
authors.lastname: Thul
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000401:mortality / Q000628:therapy; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D003424:Crohn Disease / Q000401:mortality / Q000628:therapy; D004751:Enteritis / Q000401:mortality / Q000628:therapy; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality / Q000628:therapy; D016331:Parenteral Nutrition, Home / Q000706:statistics & numerical data*; D015995:Prevalence; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D014652:Vascular Diseases / Q000401:mortality / Q000628:therapy